Expression of Ezrin,HGF,C-met in pancreatic cancer and non-cancerous pancreatic tissues of rats

被引:7
|
作者
Xing-Guo Tan and Zhu-Lin Yang Research Laboratory of Hepatobiliary Diseases
机构
关键词
pancreatic neoplasms; animal model; Ezrin; hepatocyte growth factor; C-met;
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
摘要
BACKGROUND:Recent studies have confirmed that the expression of Ezrin,hepatocyte growth factor(HGF)and its receptor(C-met)is related to the genesis,progress,invasion and metastasis of some malignant tumors.Researches have also found that the biological function of Ezrin is closely related to HGF/C-met in malignant tumors.However,there is no report on the expression levels of Ezrin,HGF and C-met in rat pancreatic cancer induced by dimethylbenzanthracene (DMBA).This study aimed to detect the expression of Ezrin, HGF and C-met in rat pancreatic cancer and non-cancerous pancreatic tissues,and assess its effect in cancer induction by DMBA. METHODS:Ninety Sprague-Dawley rats were divided into 3 groups randomly:40 in a pancreatic cancer model group (group A),40 in a trichostatin A(TSA)intervention group (group B),and 10 in a control group(group C).DMBA was directly implanted into the parenchyma of rat pancreas in group A+group B.The rats of group B were treated with 1 ml of TSA saline solution(1μg/ml)via intraperitoneal injection weekly.The carcinogenesis of rats executed within 3-5 months in groups A and B was observed by macrograph and microscopy. Meanwhile,the rats in group C were executed within 5 months. The EnVision TM immunohistochemistry for detecting the expression levels of Ezrin,HGF and C-met was used in paraffinembedded sections of the pancreatic specimens. RESULTS:The incidence of pancreatic cancer in group A was 48.6%and in group B 33.3%.The maximal diameter of tumor mass was significantly larger in group A than that in group B(P<0.05).No pathological changes were observed , in the pancreas of group C and other main organs of groups A and B.The positive rates of Ezrin,HGF and C-met were significantly higher in ductal adenocarcinoma than in non- cancerous pancreatic tissues of groups A and B(P<0.01).The positive rates of Ezrin,HGF and C-met were significantly higher in ductal adenocarcinoma of group A than those in non- cancerous pancreatic tissues of group A(P<0.05),but there was no significant difference in group B(P>0.05).The positive rates of Ezrin,HGF and C-met in non-cancerous pancreatic tissues proved mild to severe atypical hyperplasia of the ductal epithelia.The pancreas of group C and 2 cases of fibrosarcoma showed the negative expression of Ezrin,HGF and C-met.There was a trend of consistency in the expression of Ezrin,HGF and C-met in ductal adenocarcinoma(P<0.05 or P<0.01). CONCLUSIONS:DMBA directly implanted into the parenchyma of the pancreas can produce a model of pancreatic cancer with a high incidence in a short time.TSA might inhibit the carcinogenesis and growth of pancreatic cancer,and its effects may be related to the inhibition of the expression of Ezrin,HGF and C-met during the process.Ezrin,HGF and C-met may have positive effects on the carcinogenesis of rat pancreas.
引用
收藏
页码:639 / 644
页数:6
相关论文
共 50 条
  • [1] Expression of Ezrin, HGF, C-met in pancreatic cancer and non-cancerous pancreatic tissues of rats
    Tan, Xing-Guo
    Yang, Zhu-Lin
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2010, 9 (06) : 639 - 644
  • [2] Expression of DNA-repair proteins and their significance in pancreatic cancer and non-cancerous pancreatic tissues of Sprague–Dawley rats
    Xing-guo Tan
    Zhu-lin Yang
    Le-ping Yang
    Xiong-ying Miao
    World Journal of Surgical Oncology, 12
  • [3] Targeting HGF/c-MET Axis in Pancreatic Cancer
    Pothula, Srinivasa P.
    Xu, Zhihong
    Goldstein, David
    Pirola, Romano C.
    Wilson, Jeremy S.
    Apte, Minoti, V
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (23) : 1 - 18
  • [4] Correlation between hypoxia and HGF/c-MET expression in the management of pancreatic cancer
    Sharma, Rishav
    Malviya, Rishabha
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (03):
  • [5] Expression of DNA-repair proteins and their significance in pancreatic cancer and non-cancerous pancreatic tissues of Sprague-Dawley rats
    Tan, Xing-guo
    Yang, Zhu-lin
    Yang, Le-ping
    Miao, Xiong-ying
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [6] Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer
    Pothula, Srinivasa P.
    Xu, Zhihong
    Goldstein, David
    Merrett, Neil
    Pirola, Romano C.
    Wilson, Jeremy S.
    Apte, Minoti V.
    ONCOTARGET, 2017, 8 (44) : 76722 - 76739
  • [7] Pancreatic Stellate Cells Facilitate Perineural Invasion of Pancreatic Cancer via HGF/c-Met Pathway
    Nan, Ligang
    Qin, Tao
    Xiao, Ying
    Qian, Weikun
    Li, Jie
    Wang, Zheng
    Ma, Jiguang
    Ma, Qingyong
    Wu, Zheng
    CELL TRANSPLANTATION, 2019, 28 (9-10) : 1289 - 1298
  • [8] Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib
    Kim, Junyeol
    Lee, Tae Seung
    Lee, Myeong Hwan
    Cho, In Rae
    Ryu, Ji Kon
    Kim, Yong-Tae
    Lee, Sang Hyub
    Paik, Woo Hyun
    CANCERS, 2024, 16 (05)
  • [9] HGF/c-met mRNA expressions in pancreatic cancer cell and cancer stromal cell compartments
    Nakahashi, C
    Oda, T
    Aoyagi, Y
    Kinoshita, T
    Fukao, K
    Ochiai, A
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 243 - 244
  • [10] Targeting the C-MET/HGF Signaling Pathway in Pancreatic Ductal Adenocarcinoma
    Ghanaatgar-Kasbi, Sadaf
    Khorrami, Shadi
    Avan, Amir
    Aledavoud, Seyed A.
    Ferns, Gordon A.
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (39) : 4619 - 4625